Cepheid Gets Emergency Use Authorization for H1N1 Flu Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid today said that the US Food and Drug Administration has granted an Emergency Use Authorization for the firm's Xpert Flu A Panel test.

The test runs on the firm's GeneXpert System and can identify the 2009 H1N1 influenza virus in less than one hour, said Cepheid. In addition, Cepheid said that it is the first test for the virus granted an EUA for CLIA moderate complexity labs, which means it can be performed in hospital near-patient settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.